The DOI matches its Crossref record; the references it cites are not checked yet.
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors
Abstract
Angio-oedema is a rare but potentially life threatening side-effect of angiotensin-converting-enzyme (ACE) inhibitor treatment. Identification of individuals at risk of this adverse effect is not possible. Angio-oedema is associated with raised concentrations of bradykinin, which is mainly inactivated by ACE. We assessed the plasma activity of two other enzymes that catabolise bradykinin (aminopeptidase P and carboxypeptidase N) in 39 hypertensive patients with a history of angio-oedema during ACE inhibitor treatment and in 39 hypertensive patients who had never had ACE inhibitor associated side-effects. Patients with previous angio-oedema had a lower plasma activity of aminopeptidase P than did those who never presented with angio-oedema (p=0 003). Our data suggest that low plasma concentrations of aminopeptidase P could be a predisposing factor for development of angio-oedema in patients treated with ACE inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In hypertensive patients who experienced ACEi-angioedema, impaired degradation of bradykinin and des-Arg 9 -bradykinin has been associated with a decreased activity of plasma APP [Adam et al., 2002;Blais et al., 1999;Molinaro et al., 2006].”
From A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor‐induced angioedema (2011) · cites this paper as Adam et al., 2002
In the citing paper
“Previous studies have provided conflicting data regarding serum APP activity in patients with a history of ACE inhibitor-associated angioedema.”
From Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema (2010) · cites this paper as [10]
In the citing paper
“Adam et al. have previously reported decreased APP activity in the sera of 39 white patients with a history of ACE inhibitor-associated angioedema, as compared to 39 ACE inhibitor-exposed controls.[10]”
From Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema (2010) · cites this paper as [10]
In the citing paper
“We previously reported significantly lower plasma APP activities in patients with a history of AE-ACEi, which is strongly correlated with a significant decrease in desArg 9 -BK degradation in vitro (Blais et al. 1999 a ; Adam et al. 2002; Molinaro et al. 2002).”
From A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. (2005) · cites this paper as Adam et al. 2002
In the citing paper
“Supporting this notion, APP activity and des-Arg 9 -bradykinin degradation are decreased in the sera of angioedema patients of European origin compared with control subjects.13,14”
From Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema (2008) · cites this paper as [13]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 5 · Cited by 181
Metadata
- Authors
- Adam, A., Cugno, M., Molinaro, G., Perez, M., Lepage, Y., & Agostoni, A.
- Affiliations
- Université de Montréal (CA)
- University of Milan (IT)
- Corresponding author
- Adam, Albert
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 359
- Issue
- 9323
- Pages
- 2088-2089
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2017547967
- Cited by
- 181
- References
- 5
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 2 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 5 · 2015: 10 · 2014: 10 · 2013: 11 · 2012: 18
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Università degli Studi di Milano
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- aminopeptidase P, angioedema, ACE inhibitors, bradykinin, carboxypeptidase N, plasma enzyme activity, hypertension, adverse drug reactions, risk factors
- MeSH terms
- Adult, Aged, Aminopeptidases, Analysis of Variance, Angioedema, Angiotensin-Converting Enzyme Inhibitors, Lysine Carboxypeptidase, Humans, Hypertension, Middle Aged, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. https://app.cochat.ai/papers/10.1016/s0140-6736(02)08914-6
- The paper
- Adam, A., Cugno, M., Molinaro, G., Perez, M., Lepage, Y., & Agostoni, A. (2002). Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. The Lancet. https://doi.org/10.1016/s0140-6736(02)08914-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.